Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Vehicle Controlled, Double Blind, Multicenter, Randomized, Phase II Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Mild to Moderate Atopic Dermatitis

NCT03235024 is registered in ClinicalTrials.gov with AOBiome LLC as lead sponsor.

NCT NCT03235024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03235024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Vehicle Controlled, Double Blind, Multicenter, Randomized, Phase II Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Mild to Moderate Atopic Dermatitis
Lead sponsor
AOBiome LLC
Phase
Phase 2
Overall status
Completed
Start date
January 15, 2018
Completion date
March 20, 2019
Enrollment
122 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis eczema